Splash Pharmaceuticals

Splash Pharmaceuticals is a cancer therapy company. It aims at developing a therapy with a response in solid tumors. Its therapy SPL-108 is being trialed in combination with paclitaxel in patients with platinum-resistant, CD44+, advanced ovarian epithelial cancer.